ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Deferred Revenue
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Deferred Revenue of $443.83 thousand for the 9-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2021-08-12
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in deferred revenue for the quarter ending 2021-06-30 was -$43.28K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in deferred revenue for the quarter ending 2020-06-30 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month |
|---|---|---|---|
| 2021-06-30 | -$43.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $443.83K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $487.11K 10-Q · filed 2021-05-13 | ||
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |